UK Report Highlights Call for More Inclusive and Accessible Medicines Research and Care

A new UK report calls for more inclusive, accessible medicines research and healthcare practices, highlighting stakeholder insights on improving the entire medicines lifecycle from discovery to use.
A comprehensive new report released in the UK on June 23, 2025, underscores the urgent need to make medicines research and healthcare more inclusive and accessible for all. Led by researchers from the University of Liverpool, Manchester Metropolitan University, and University College London, the study engaged both the public and healthcare professionals through workshops and discussions to gather diverse perspectives on the entire lifecycle of medicines, from discovery to everyday use.
The report, titled "Better Medicines: Public and Professional Views on the Lifecycle from Discovery to Taking Medicines," reflects a wide range of insights across the healthcare and life sciences sectors, including experiences of patients, clinicians, researchers, industry experts, and regulators. It emphasizes that while there is widespread trust in the scientific advancements and safety processes, there are notable gaps and opportunities for improvement.
Key findings reveal that both the public and professionals agree on the significant positive impact of medicines on health outcomes and express admiration for the UK's publicly funded healthcare system. However, they also identify disparities and areas needing attention, such as reaching underrepresented groups, addressing regional inequalities, and tackling systemic barriers in research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Study Reveals Vepdegestrant Extends Survival in Patients with Advanced ER+ Breast Cancer Featuring ESR1 Mutations
A new clinical trial reveals that vepdegestrant significantly improves progression-free survival in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutations. Learn about the latest advancements in targeted breast cancer therapy.
Debunking the Overhyped Claims of Magic Mushrooms and Anti-Aging
Recent studies suggest psilocybin from magic mushrooms may promote cellular longevity, but experts warn these claims are overblown and not applicable to humans due to high-dose risks and limited evidence.
Long-Term Cardiac Microvascular Changes in Severe COVID-19 Survivors
Severe COVID-19 survivors may experience prolonged cardiac microvascular dysfunction, impacting blood flow and heart function. New research underscores the importance of understanding these lasting effects for better treatment options.
'Single shot' malaria vaccine delivery system could transform global immunization
A groundbreaking microcapsule-based vaccine delivery system developed by Oxford scientists could enable single-injection immunization, improving coverage and simplifying vaccination programs worldwide.



